Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 170 entries
Sorted by: Best Match Show Resources per page
Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol.

NDT plus

Elmholdt TR, Jørgensen B, Ramsing M, Pedersen M, Olesen AB.
PMID: 28657062
NDT Plus. 2010 Jun;3(3):285-287. doi: 10.1093/ndtplus/sfq028. Epub 2010 Mar 19.

Nephrogenic systemic fibrosis (NSF) is a disease with progressive fibrosis. We describe two cases of NSF after exposure to a macrocyclic gadolinium-based contrast agent (GBCA) gadobutrol, which has been considered as a low-risk agent compared to linear GBCAs. The...

Cite
Elmholdt TR, Jørgensen B, Ramsing M, et al. Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol. NDT Plus. 2010;3(3):285-287doi: 10.1093/ndtplus/sfq028.
Elmholdt, T. R., Jørgensen, B., Ramsing, M., Pedersen, M., & Olesen, A. B. (2010). Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol. NDT plus, 3(3), 285-287. https://doi.org/10.1093/ndtplus/sfq028
Elmholdt, Tina Rask, et al. "Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol." NDT plus vol. 3,3 (2010): 285-287. doi: https://doi.org/10.1093/ndtplus/sfq028
Elmholdt TR, Jørgensen B, Ramsing M, Pedersen M, Olesen AB. Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol. NDT Plus. 2010 Jun;3(3):285-287. doi: 10.1093/ndtplus/sfq028. Epub 2010 Mar 19. PMID: 28657062; PMCID: PMC5477958.
Copy Download .nbib Format: NLM
The application of RNAi-based treatments for inflammatory bowel disease.

Drug delivery and translational research

Olesen MT, Ballarín-González B, Howard KA.
PMID: 25786614
Drug Deliv Transl Res. 2014 Feb;4(1):4-18. doi: 10.1007/s13346-013-0156-9.

Inflammatory bowel disease (IBD) is a chronic, relapsing, idiopathic inflammation of the gastrointestinal tract with no permanent cure. Present immunosuppressive and anti-inflammatory therapies are often ineffective and associated with severe side effects. An RNA interference (RNAi)-based approach in which...

Cite
Olesen MT, Ballarín-González B, Howard KA. The application of RNAi-based treatments for inflammatory bowel disease. Drug Deliv Transl Res. 2014;4(1):4-18doi: 10.1007/s13346-013-0156-9.
Olesen, M. T., Ballarín-González, B., & Howard, K. A. (2014). The application of RNAi-based treatments for inflammatory bowel disease. Drug delivery and translational research, 4(1), 4-18. https://doi.org/10.1007/s13346-013-0156-9
Olesen, Morten Tobias Jarlstad, et al. "The application of RNAi-based treatments for inflammatory bowel disease." Drug delivery and translational research vol. 4,1 (2014): 4-18. doi: https://doi.org/10.1007/s13346-013-0156-9
Olesen MT, Ballarín-González B, Howard KA. The application of RNAi-based treatments for inflammatory bowel disease. Drug Deliv Transl Res. 2014 Feb;4(1):4-18. doi: 10.1007/s13346-013-0156-9. PMID: 25786614.
Copy Download .nbib Format: NLM
Chemical identification of point defects and adsorbates on a metal oxide surface by atomic force microscopy.

Nanotechnology

Lauritsen JV, Foster AS, Olesen GH, Christensen MC, Kühnle A, Helveg S, Rostrup-Nielsen JR, Clausen BS, Reichling M, Besenbacher F.
PMID: 19661587
Nanotechnology. 2006 Jul 28;17(14):3436-41. doi: 10.1088/0957-4484/17/14/015. Epub 2006 Jun 20.

Atomic force microscopy in the non-contact mode (nc-AFM) can provide atom-resolved images of the surface of, in principle, any material independent of its conductivity. Due to the complex mechanisms involved in the contrast formation in nc-AFM imaging, it is,...

Cite
Lauritsen JV, Foster AS, Olesen GH, et al. Chemical identification of point defects and adsorbates on a metal oxide surface by atomic force microscopy. Nanotechnology. 2006;17(14):3436-41doi: 10.1088/0957-4484/17/14/015.
Lauritsen, J. V., Foster, A. S., Olesen, G. H., Christensen, M. C., Kühnle, A., Helveg, S., Rostrup-Nielsen, J. R., Clausen, B. S., Reichling, M., & Besenbacher, F. (2006). Chemical identification of point defects and adsorbates on a metal oxide surface by atomic force microscopy. Nanotechnology, 17(14), 3436-41. https://doi.org/10.1088/0957-4484/17/14/015
Lauritsen, Jeppe V, et al. "Chemical identification of point defects and adsorbates on a metal oxide surface by atomic force microscopy." Nanotechnology vol. 17,14 (2006): 3436-41. doi: https://doi.org/10.1088/0957-4484/17/14/015
Lauritsen JV, Foster AS, Olesen GH, Christensen MC, Kühnle A, Helveg S, Rostrup-Nielsen JR, Clausen BS, Reichling M, Besenbacher F. Chemical identification of point defects and adsorbates on a metal oxide surface by atomic force microscopy. Nanotechnology. 2006 Jul 28;17(14):3436-41. doi: 10.1088/0957-4484/17/14/015. Epub 2006 Jun 20. PMID: 19661587.
Copy Download .nbib Format: NLM
Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose.

Biotechnology and bioengineering

Bjerre AB, Olesen AB, Fernqvist T, Plöger A, Schmidt AS.
PMID: 18623619
Biotechnol Bioeng. 1996 Mar 05;49(5):568-77. doi: 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.0.CO;2-6.

The wet oxidation process of wheat straw has been studied as a pretreatment method to attain our main goal: To break down cellulose to glucose enzymatic, and secondly, to dissolve hemicellulose (e.g., for fermentation) without producing microbial inhibitors. Wet...

Cite
Bjerre AB, Olesen AB, Fernqvist T, et al. Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose. Biotechnol Bioeng. 1996;49(5):568-77doi: 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.0.CO;2-6.
Bjerre, A. B., Olesen, A. B., Fernqvist, T., Plöger, A., & Schmidt, A. S. (1996). Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose. Biotechnology and bioengineering, 49(5), 568-77. https://doi.org/10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.0.CO;2-6
Bjerre, A B, et al. "Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose." Biotechnology and bioengineering vol. 49,5 (1996): 568-77. doi: https://doi.org/10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.0.CO;2-6
Bjerre AB, Olesen AB, Fernqvist T, Plöger A, Schmidt AS. Pretreatment of wheat straw using combined wet oxidation and alkaline hydrolysis resulting in convertible cellulose and hemicellulose. Biotechnol Bioeng. 1996 Mar 05;49(5):568-77. doi: 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.0.CO;2-6. PMID: 18623619.
Copy Download .nbib Format: NLM
Erratum: Boiling of strange-quark matter.

Physical review. D, Particles and fields

Madsen J, Olesen ML.
PMID: 10013913
Phys Rev D Part Fields. 1991 Jul 15;44(2):566. doi: 10.1103/physrevd.44.566.

No abstract available.

Cite
Madsen J, Olesen ML. Erratum: Boiling of strange-quark matter. Phys Rev D Part Fields. 1991;44(2):566doi: 10.1103/physrevd.44.566.
Madsen, J., & Olesen, M. L. (1991). Erratum: Boiling of strange-quark matter. Physical review. D, Particles and fields, 44(2), 566. https://doi.org/10.1103/physrevd.44.566
Madsen, and Olesen. "Erratum: Boiling of strange-quark matter." Physical review. D, Particles and fields vol. 44,2 (1991): 566. doi: https://doi.org/10.1103/physrevd.44.566
Madsen J, Olesen ML. Erratum: Boiling of strange-quark matter. Phys Rev D Part Fields. 1991 Jul 15;44(2):566. doi: 10.1103/physrevd.44.566. PMID: 10013913.
Copy Download .nbib Format: NLM
Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.

BMJ open respiratory research

Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ.
PMID: 29531748
BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF), a progressive life-limiting lung disease affects approximately 128 000 newly diagnosed individuals in the USA annually. IPF, a disease of ageing associated with intense medical and financial burden, is expected to grow in incidence...

Cite
Lindell KO, Nouraie M, Klesen MJ, et al. Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations. BMJ Open Respir Res. 2018;5(1):e000272doi: 10.1136/bmjresp-2017-000272.
Lindell, K. O., Nouraie, M., Klesen, M. J., Klein, S., Gibson, K. F., Kass, D. J., & Rosenzweig, M. Q. (2018). Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations. BMJ open respiratory research, 5(1), e000272. https://doi.org/10.1136/bmjresp-2017-000272
Lindell, Kathleen Oare, et al. "Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations." BMJ open respiratory research vol. 5,1 (2018): e000272. doi: https://doi.org/10.1136/bmjresp-2017-000272
Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ. Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations. BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018. PMID: 29531748; PMCID: PMC5844378.
Copy Download .nbib Format: NLM
Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study.

Clinical epidemiology

Lamberg AL, Olesen AB, Jensen AØ.
PMID: 22135503
Clin Epidemiol. 2011;3:285-93. doi: 10.2147/CLEP.S25650. Epub 2011 Nov 17.

BACKGROUND: Vitamin D deficiency is associated with osteoporotic fractures, such as hip fracture. Sun exposure, the natural source of vitamin D, is the main risk factor for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). In this study,...

Cite
Lamberg AL, Olesen AB, Jensen AØ. Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study. Clin Epidemiol. 2011;3:285-93doi: 10.2147/CLEP.S25650.
Lamberg, A. L., Olesen, A. B., & Jensen, A. �. �. (2011). Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study. Clinical epidemiology, 3285-93. https://doi.org/10.2147/CLEP.S25650
Lamberg, Anna Lei, et al. "Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study." Clinical epidemiology vol. 3 (2011): 285-93. doi: https://doi.org/10.2147/CLEP.S25650
Lamberg AL, Olesen AB, Jensen AØ. Hip fracture history and risk of nonmelanoma skin cancer: a Danish population-based study. Clin Epidemiol. 2011;3:285-93. doi: 10.2147/CLEP.S25650. Epub 2011 Nov 17. PMID: 22135503; PMCID: PMC3224634.
Copy Download .nbib Format: NLM
Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation.

Journal of clinical medicine

Vad OB, Paludan-Müller C, Ahlberg G, Kalstø SM, Ghouse J, Andreasen L, Haunsø S, Tveit A, Sajadieh A, Christophersen IE, Svendsen JH, Olesen MS.
PMID: 32013268
J Clin Med. 2020 Jan 29;9(2). doi: 10.3390/jcm9020372.

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it is associated with an increased risk of heart failure, stroke, dementia, and death. Recently, titin-truncating variants (TTNtv), which are predominantly associated with dilated cardiomyopathy (DCM), were associated with...

Cite
Vad OB, Paludan-Müller C, Ahlberg G, et al. Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation. J Clin Med. 2020;9(2)doi: 10.3390/jcm9020372.
Vad, O. B., Paludan-Müller, C., Ahlberg, G., Kalstø, S. M., Ghouse, J., Andreasen, L., Haunsø, S., Tveit, A., Sajadieh, A., Christophersen, I. E., Svendsen, J. H., & Olesen, M. S. (2020). Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation. Journal of clinical medicine, 9(2), . https://doi.org/10.3390/jcm9020372
Vad, Oliver Bundgaard, et al. "Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation." Journal of clinical medicine vol. 9,2 (2020). doi: https://doi.org/10.3390/jcm9020372
Vad OB, Paludan-Müller C, Ahlberg G, Kalstø SM, Ghouse J, Andreasen L, Haunsø S, Tveit A, Sajadieh A, Christophersen IE, Svendsen JH, Olesen MS. Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation. J Clin Med. 2020 Jan 29;9(2). doi: 10.3390/jcm9020372. PMID: 32013268; PMCID: PMC7074234.
Copy Download .nbib Format: NLM
Experimental articular cartilage repair in the Göttingen minipig: the influence of multiple defects per knee.

Journal of experimental orthopaedics

Christensen BB, Foldager CB, Olesen ML, Vingtoft L, Rölfing JH, Ringgaard S, Lind M.
PMID: 26914881
J Exp Orthop. 2015 Dec;2(1):13. doi: 10.1186/s40634-015-0031-3. Epub 2015 Jun 18.

BACKGROUND: A gold standard treatment for articular cartilage injuries is yet to be found, and a cost-effective and predictable large animal model is needed to bridge the gap between in vitro studies and clinical studies. Ideally, the animal model...

Cite
Christensen BB, Foldager CB, Olesen ML, et al. Experimental articular cartilage repair in the Göttingen minipig: the influence of multiple defects per knee. J Exp Orthop. 2015;2(1):13doi: 10.1186/s40634-015-0031-3.
Christensen, B. B., Foldager, C. B., Olesen, M. L., Vingtoft, L., Rölfing, J. H., Ringgaard, S., & Lind, M. (2015). Experimental articular cartilage repair in the Göttingen minipig: the influence of multiple defects per knee. Journal of experimental orthopaedics, 2(1), 13. https://doi.org/10.1186/s40634-015-0031-3
Christensen, Bjørn Borsøe, et al. "Experimental articular cartilage repair in the Göttingen minipig: the influence of multiple defects per knee." Journal of experimental orthopaedics vol. 2,1 (2015): 13. doi: https://doi.org/10.1186/s40634-015-0031-3
Christensen BB, Foldager CB, Olesen ML, Vingtoft L, Rölfing JH, Ringgaard S, Lind M. Experimental articular cartilage repair in the Göttingen minipig: the influence of multiple defects per knee. J Exp Orthop. 2015 Dec;2(1):13. doi: 10.1186/s40634-015-0031-3. Epub 2015 Jun 18. PMID: 26914881; PMCID: PMC4538720.
Copy Download .nbib Format: NLM
Particulated Cartilage for Chondral and Osteochondral Repair: A Review.

Cartilage

Christensen BB, Olesen ML, Hede KTC, Bergholt NL, Foldager CB, Lind M.
PMID: 32052642
Cartilage. 2020 Feb 13;1947603520904757. doi: 10.1177/1947603520904757. Epub 2020 Feb 13.

INTRODUCTION: Injuries to articular cartilage have a poor spontaneous repair potential and no gold standard treatment exist. Particulated cartilage, both auto- and allograft, is a promising new treatment method that circumvents the high cost of scaffold- and cell-based treatments.MATERIALS...

Cite
Christensen BB, Olesen ML, Hede KTC, et al. Particulated Cartilage for Chondral and Osteochondral Repair: A Review. Cartilage. 2020;1947603520904757doi: 10.1177/1947603520904757.
Christensen, B. B., Olesen, M. L., Hede, K. T. C., Bergholt, N. L., Foldager, C. B., & Lind, M. (2020). Particulated Cartilage for Chondral and Osteochondral Repair: A Review. Cartilage, 1947603520904757. https://doi.org/10.1177/1947603520904757
Christensen, Bjørn Borsøe, et al. "Particulated Cartilage for Chondral and Osteochondral Repair: A Review." Cartilage vol. (2020): 1947603520904757. doi: https://doi.org/10.1177/1947603520904757
Christensen BB, Olesen ML, Hede KTC, Bergholt NL, Foldager CB, Lind M. Particulated Cartilage for Chondral and Osteochondral Repair: A Review. Cartilage. 2020 Feb 13;1947603520904757. doi: 10.1177/1947603520904757. Epub 2020 Feb 13. PMID: 32052642.
Copy Download .nbib Format: NLM
Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes.

European heart journal. Cardiovascular pharmacotherapy

Ghouse J, Blanche P, Skov MW, Lind B, Vaag A, Kanters JK, Svendsen JH, Køber L, Olesen MS, Gerds TA, Holst AG, Nielsen JB.
PMID: 32614428
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 03;7(6):486-495. doi: 10.1093/ehjcvp/pvaa072.

AIMS: To determine the risk of major adverse cardiovascular events (MACE) and death, associated with an early large and rapid decline in glycated haemoglobin (HbA1C) following first time initiation of an oral antidiabetic drug (OAD).METHODS AND RESULTS: We included...

Cite
Ghouse J, Blanche P, Skov MW, et al. Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2021;7(6):486-495doi: 10.1093/ehjcvp/pvaa072.
Ghouse, J., Blanche, P., Skov, M. W., Lind, B., Vaag, A., Kanters, J. K., Svendsen, J. H., Køber, L., Olesen, M. S., Gerds, T. A., Holst, A. G., & Nielsen, J. B. (2021). Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. European heart journal. Cardiovascular pharmacotherapy, 7(6), 486-495. https://doi.org/10.1093/ehjcvp/pvaa072
Ghouse, Jonas, et al. "Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes." European heart journal. Cardiovascular pharmacotherapy vol. 7,6 (2021): 486-495. doi: https://doi.org/10.1093/ehjcvp/pvaa072
Ghouse J, Blanche P, Skov MW, Lind B, Vaag A, Kanters JK, Svendsen JH, Køber L, Olesen MS, Gerds TA, Holst AG, Nielsen JB. Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 03;7(6):486-495. doi: 10.1093/ehjcvp/pvaa072. PMID: 32614428.
Copy Download .nbib Format: NLM
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.

Lancet (London, England)

Svendsen JH, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Kronborg C, Olesen MS, Nielsen JB, Holst AG, Brandes A, Haugan KJ, Køber L.
PMID: 34469766
Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29.

BACKGROUND: It is unknown whether screening for atrial fibrillation and subsequent treatment with anticoagulants if atrial fibrillation is detected can prevent stroke. Continuous electrocardiographic monitoring using an implantable loop recorder (ILR) can facilitate detection of asymptomatic atrial fibrillation episodes....

Cite
Svendsen JH, Diederichsen SZ, Højberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021;398(10310):1507-1516doi: 10.1016/S0140-6736(21)01698-6.
Svendsen, J. H., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Kronborg, C., Olesen, M. S., Nielsen, J. B., Holst, A. G., Brandes, A., Haugan, K. J., & Køber, L. (2021). Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet (London, England), 398(10310), 1507-1516. https://doi.org/10.1016/S0140-6736(21)01698-6
Svendsen, Jesper H, et al. "Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial." Lancet (London, England) vol. 398,10310 (2021): 1507-1516. doi: https://doi.org/10.1016/S0140-6736(21)01698-6
Svendsen JH, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Kronborg C, Olesen MS, Nielsen JB, Holst AG, Brandes A, Haugan KJ, Køber L. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29. PMID: 34469766.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 170 entries